Dual inhibition of factor XIIa and factor XIa as a therapeutic approach for safe thromboprotection

Stéphanie DemoulinA, Godfroid EdmondA, Cédric HermansA

Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass

Valérie PireauxA, Tassignon JoëlA, Stéphanie DemoulinA, Sandrine DerochetteA, Nicolas BorensteinA, Angélique EnteA, Laurence FietteA, Jonathan DouxfilsA, Patrizio LancellottiA, Michel GuyauxA, Edmond GodfroidA

Are Ticks the Answer to Medical Device-Associated Clotting?

Jeffrey I. WeitzA, Noel C. ChanA

Ir-CPI: an original inhibitor of thrombosis and thrombosis-associated with cancer

Roxane DarboussetA, Valérie PireauxA, Lydie CrescenceA, Stéphanie DemoulinA, Laurence Panicot-DuboisA, Edmond GodfroidA, Christophe DuboisA

Efficacy of a novel contact pathway inhibitor, Ir-CPI, in an extracorporeal membrane oxygenator model

Sophie CombeA, Yves FromesA, Chantal KrezelA, Pierre GueretA, Michel GuyauxA, Edmond GodfroidA, Jean AmiralA

Evaluation of the effects of a novel contact pathway inhibitor, Ir-CPI, on in vitro platelet function and coagulation

Jayaprakash KothaA, Juan Manuel CardenasA, Michael HerrA, Vinay BhalA, Mason DixonA, Melanie WhiteA, Sophie CombeA, Edmond GodfroidA, Lisa JenningsA

Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis

Yves DecremA, Géraldine RathA, Virginie BlasioliA, Philippe CauchieA, Séverine RobertA, Jérôme BeaufaysA, Jean-Marie FrèreA, Olivier FeronA, Jean-Michel DognéA, Chantal DessyA, Luc VanhammeA, Godfroid EdmondA